NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Malaria testing still under discussion – IBTS

By Mindo - 06th Jul 2021

Lab technician in protective visor and gloves taking stick with saliva sample from COVID-19 test kit for analysis

The introduction of malaria testing for some potential blood donors remains under discussion as changes to the computer system are required, according to the Irish Blood Transfusion Service (IBTS). The changes are necessary to ensure that “those donors exposed to malaria are appropriately selected for testing”.

Currently, people must wait 12 months from the day they leave a malaria-affected country/area before becoming eligible to donate. Additionally, people cannot give blood if they ever had malaria, even if fully recovered.

For a number of years, the IBTS has been planning to introduce an adapted policy involving malaria antibody testing for some potential donors. Ireland now has a significant cohort of children and adults with transfusion-dependent sickle cell disease (SCD), a genetic blood disorder predominantly affecting people of African background.

Recruiting more donors of African background to better match blood for SCD patients would help reduce the pressure on O negative blood stocks. O negative is considered the universal blood group and is always in demand, according to the IBTS.

From January to May 2021, O negative issues were at 14.9 per cent (while the incidence of O negative in the population is around 9 per cent).

In late June, the IBTS announced it was importing 115 units of Rh negative blood groups (O negative, A negative, and B negative) from NHS Blood and Transplant. The shortage relates to increased hospital activity and a recent decline in donations due to various factors.

Leave a Reply

Latest Issue
medical independent 5th December
The Medical Independent 5th December 2023

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read